U.S. Markets open in 4 hrs 7 mins

Wall Street Analysts Are Mostly Positive on Celgene in June

Daniel Collins
Wall Street Analysts Are Mostly Positive on Celgene in June

Celgene (CELG) reported revenues of $3.5 billion in Q1 2018, which reflected ~20% year-over-year (or YoY) growth and 1% growth sequentially. In Q1 2018, Celgene’s adjusted diluted EPS (earnings per share) rose ~23% YoY to reach $2.05. In Q1 2018, Celgene reported a gross product margin and an operating margin of 96.4% and 57.9%, respectively.